CDK9-IN-13
Product Specifications
UNSPSC Description
CDK9-IN-13 (compound 38) is potent and selective CDK9 inhibitor, with an IC50 of [1].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk9-in-13.html
Solubility
DMSO : 2.5 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
CC(C)N1C=C(C2=CC=NC3=C2C=C(C4CCN(CC(N5CCCCC5)=O)CC4)N3)C=CC1=O
Molecular Weight
461.60
References & Citations
[1]Barlaam B, et, al. Discovery of a Series of 7-Azaindoles as Potent and Highly Selective CDK9 Inhibitors for Transient Target Engagement. J Med Chem. 2021 Oct 28;64(20):15189-15213.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-139980/CDK9-IN-13-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-139980/CDK9-IN-13-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2768712-71-4
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
